Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of esketamine for pediatric day-surgery circumcision
ChiCTR2100042556Phase 4Recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of esketamine in phimosis and Redundant prepuce, sponsored by Shanghai Children's Medical Center. Primary endpoint: dose of esketamine. Started Mar 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
phimosisRedundant prepuce
Beyond the preview
Go deeper on ChiCTR2100042556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042556.